IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 33 filers reported holding IMPEL NEUROPHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,020 | -70.4% | 16,325 | -12.4% | 0.01% | -68.8% |
Q2 2023 | $23,680 | -9.3% | 18,646 | 0.0% | 0.02% | -11.1% |
Q1 2023 | $26,104 | -62.7% | 18,646 | 0.0% | 0.02% | -61.7% |
Q4 2022 | $69,923 | -23.2% | 18,646 | 0.0% | 0.05% | -16.1% |
Q3 2022 | $91,000 | -47.7% | 18,646 | 0.0% | 0.06% | -47.7% |
Q2 2022 | $174,000 | +46.2% | 18,646 | 0.0% | 0.11% | +67.2% |
Q1 2022 | $119,000 | -26.1% | 18,646 | 0.0% | 0.06% | -25.6% |
Q4 2021 | $161,000 | – | 18,646 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NVP Associates, LLC | 3,077,198 | $1,323,195 | 1.18% |
5AM Venture Management, LLC | 2,884,791 | $1,240,460 | 0.36% |
venBio Partners LLC | 2,759,791 | $1,186,710 | 0.34% |
Vivo Capital, LLC | 2,884,789 | $1,240,459 | 0.14% |
LASRY MARC | 225,874 | $97,126 | 0.10% |
Kohlberg Kravis Roberts & Co. L.P. | 4,135,971 | $1,778,468 | 0.06% |
DCF Advisers, LLC | 178,500 | $76,755 | 0.04% |
EPIQ PARTNERS, LLC | 16,325 | $7,020 | 0.01% |
MCDONALD PARTNERS LLC | 19,400 | $8,342 | 0.00% |
XTX Topco Ltd | 21,222 | $9,125 | 0.00% |